The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy

Molecular Genetics and Metabolism

Volumn 106, Issue 2, 2012, Pages 231-236

  Rockenbach, Francieli J ^a   Deon, Marion ^a,b   Marchese, Daiane P ^b   Manfredini, Vanusa ^c   Mescka, Caroline ^a   Ribas, Graziela S ^a,b   Habekost, Clarissa T ^b   Castro, Claudio G ^b   Jardim, Laura B ^b   Vargas, Carmen R ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIPAMPA   (Brazil)

Author keywords

Adrenoleukodystrophy; Bone marrow transplantation; Free radicals; Lipid peroxidation; Oxidative stress; Protein damage

Indexed keywords

ACID; CARBONYL DERIVATIVE; HEXACOSANOIC ACID; MALONALDEHYDE; THIOL GROUP; UNCLASSIFIED DRUG;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ARTICLE; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; METABOLIC PARAMETERS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METABOLISM; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADRENOLEUKODYSTROPHY; BLOOD PROTEINS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; HUMANS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS;

EID: 84860917002     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.03.019     Document Type: Article

References (41)

1. Bezman L., Moser A.B., Raymond G.V., Rinaldo P., Watkins P.A., Smith K.D., Kass N.E., Moser H.W. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann. Neurol. 2001, 49:512-517.
2. Moser H.W., Smith K.D., Watkins P.A., Powers J., Moser A.B. X-linked adrenoleukodystrophy. The Metabolic and Molecular Bases of Inherited Disease 2001, 3257-3301. McGraw-Hill Inc., New York. eight ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
3. Moser A.B., Kreiter N., Bezman L., Lu S., Raymond G.V., Naidu S., Moser H.W. Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 1999, 45(1):100-110.
4. Moser H.W., Raymond G.V., Dubey P. Adrenoleukodystrophy - new approaches to a neurodegenerative disease. JAMA 2005, 294:3131-3134.
5. Moser H.W. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997, 120:1485-1508.
6. Van Geel B.M., Assies J., Wanders R.J., Barth P.G. X-linked adrenoleukodystrohy: clinical presentation, diagnosis and theraphy. J. Neurol. Neurosurg. Psychiatry 1997, 63(1):4-14.
7. Moser H.W. Therapy of X-linked adrenoleukodystrophy. NeuroRx 2006, 3:246-253.
8. Moser H.W., Raymond G.V., Lu S.E., Muenz L.R., Moser A.B., Xu J., Jones R.O., Loes D.J., Melhem E.R., Dubey P., Bezman L., Brereton N.H., Odone A. 2005a. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Arch. Neurol. 2005, 62(7):1073-1080.
9. Berger J., Gärtner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetics aspects. Biochim. Biophys. Acta 2006, 1763:1721-1732.
10. Loes D.J., Fatemi A., Melhem E.R., Gupte N., Bezman L., Moser H.W., Raymond G.V. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003, 61:369-374.
11. Peters C., Charnas L.R., Tan Y., Ziegler R.S., Shapiro E.G., DeFor T., Grewal S.S., Orchard P.J., Abel S.L., Goldman A., Ramsay N.K., Dusenbery K.E., Loes D.J., Lockman L.A., Kato S., Aubourg P.R., Moser H.W., Krivit W. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004, 104(3):881-888.
12. Beam D., Poe M.D., Provenzale J.M., Szabolcs P., Martin P.L., Prasad V., Parikh S., Driscoll T., Mukundan S., Kurtzberg J., Escolar M.L. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol. Blood Marrow Transplant. 2007, 13(6):665-674.
13. Shapiro E., Krivit W., Lockman L., Jambaqué I., Peters C., Cowan M., Harris R., Blanche S., Bordigoni P., Loes D., Ziegler R., Crittenden M., Ris D., Berg B., Cox C., Moser H., Fischer A., Aubourg P. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000, 356(9231):713-718.
14. Baumann M., Korenke G.C., Weddige-Diedrichs A., Wilichowski E., Hunneman D.H., Wilken B., Brockmann K., Klingebiel T., Niethammer D., Kuhl J., Ebell W., Hanefeld F. Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy. Eur. J. Pediatr. 2003, 162:6-14.
15. Mahmood A., Dubey P., Moser H.W., Moser A. X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes. Pediatr. Transplant. 2005, 9(Suppl. 7):55-62.
16. Resnick I.B., Abdul Hai A., Shapira M.Y., Bitan M., Hershkovitz E., Schwartz A., Ben-Harush M., Or R., Slavin S., Kapelushnik J. Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen. Clin. Transplant. 2005, 19:840-847.
17. Free radicals in Biology and Medicine 2007, 704. Oxford University Press, Oxford. 4 ed. B. Halliwell, J.M.C. Gutteridge (Eds.).
18. Vargas C.R., Wajner M., Sirtori L.R., Goulart L., Chiochetta M., Coelho D., Latini A., Llesuy S., Bello'-Klein A., Giugliani R., Deon M., Mello C.F. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim. Biophys. Acta 2004, 1688:26-32.
19. Deon M., Wajner M., Sirtori L.R., Fitarelli D., Coelho D., Sitta A., Barschak A.G., Ferreira G.C., Haeser A., Giugliani R., Vargas C.R. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy. J. Neurol. Sci. 2006, 247:157-164.
20. Deon M., Sitta A., Barschak A.G., Coelho D.M., Pigatto M., Schmitt G.O., Wanderley H.Y., Jardim L.B., Giugliani R., Wajner M., Vargas C.R. Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy. Int. J. Dev. Neurosci. 2007, 25:441-444.
21. Deon M., Sitta A., Barschak A.G., Coelho D.M., Terroso T., Schmitt G.O., Wanderley H.Y., Jardim L.B., Giugliani R., Wajner M., Vargas C.R. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy. J. Neurol. Sci. 2008, 266:79-83.
22. Di Biase A., Benedetto R., Fiorentini C., Travaglione S., Salvati S., Attorri L., Pietraforte D. Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis. Neurochem. Int. 2004, 44:215-221.
23. Di Biase A., Benedetto R., Salvati S., Attorri L., Leonardi F., Pietraforte D. Effects of l-mono methyl-arginine, N-acetyl-cysteine and diphenyleniodonium on free radical release in C6 glial cells enriched in hexacosanoic acid. Neurochem. Res. 2005, 30(2):215-223.
24. Fourcarde S., López-Erauskin J., Galino J., Duval C., Naudi A., Jove M., Kemp S., Villarroya F., Ferrer I., Pamplona R., Portero-Otin M., Pujol A. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum. Mol. Genet. 2008, 17:1762-1773.
25. Moser H.W., Moser A.B. Measurement of saturated very long chain fatty acid in plasma. Techniques of Diagnostic Human Biochemical Genetics 1991, 177-191. Wiley, New York. F.A. Hommes (Ed.).
26. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186:407-421.
27. Aksenov M.Y., Markesbery W.R. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci. Lett. 2001, 302:141-145.
28. Stadtman E.R., Levine R.L. Free-radical mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003, 25:207-218.
29. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-478.
30. Gornall A.G., Bardawill C.J., David M.M. Determination of serum proteins by means of the Biuret reaction. J. Biol. Chem. 1949, 177:751-766.
31. Moser H.W., Loes D.J., Melhem E.R., Raymond G.V., Bezman L., Cox C.S. X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 2000, 31:227-239.
32. Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 2009, 65(Suppl. 1):S3-S9.
33. Zhou C., Huang Y., Przedborski S. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. N. Y. Acad. Sci. 2008, 1147:93-104.
34. Powers J.M., Pei Z., Keinzer A.K., Deering R., Moser A.B., Moser H.W., Watkins P.A., Smith K.D. Adrenoleukodystrophy: oxidative stress of mice and men. J. Neuropathol. Exp. Neurol. 2005, 64(12):1067-1079.
35. Uto T., Contreras M.A., Gilg A.G., Singh I. Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. Dev. Neurosci. 2008, 30:410-418.
36. Deuticke B. The role of membrane sulfhydryls in passive, mediated transport processes and for the barrier functions of the erythrocyte membrane. Membr. Biochem. 1986, 6(4):309-326.
37. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 2004, 142:231-255.
38. Requejo R., Hurd T.R., Costa N.J., Murphy M.P. Cystein residues exposed on protein surfaces are dominant intramitochondrial thiol and may protect against oxidative damage. FEBS J. 2010, 277:1465-1480.
39. Cartier N., Aubourg P. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy. Brain Pathol. 2010, 20:857-862.
40. Tolar J., Orchard P.J., Bjoraker K.J., Ziegler R.S., Shapiro E.G., Charnas L. N-acetyl-l-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant. 2007, 39:211-215.
41. Orchard P.S., Lund T., Miller W., Rothman S.M., Raymond G., Nascene D., Basso L., Cloyd J., Tolar J. Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J. Neuroinflammation 2011, 8:144.